nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Dacarbazine—muscle cancer	0.131	0.251	CbGbCtD
Maprotiline—ABCB1—Dactinomycin—muscle cancer	0.099	0.19	CbGbCtD
Maprotiline—CYP1A2—Etoposide—muscle cancer	0.0639	0.123	CbGbCtD
Maprotiline—ABCB1—Vincristine—muscle cancer	0.061	0.117	CbGbCtD
Maprotiline—ABCB1—Etoposide—muscle cancer	0.0559	0.107	CbGbCtD
Maprotiline—ABCB1—Doxorubicin—muscle cancer	0.0381	0.0731	CbGbCtD
Maprotiline—ABCB1—Methotrexate—muscle cancer	0.0369	0.0708	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—muscle cancer	0.0359	0.0689	CbGbCtD
Maprotiline—CHRM3—muscle of abdomen—muscle cancer	0.0175	0.208	CbGeAlD
Maprotiline—HTR2A—hindlimb—muscle cancer	0.00532	0.0633	CbGeAlD
Maprotiline—HTR2A—appendage—muscle cancer	0.00456	0.0543	CbGeAlD
Maprotiline—CHRM4—head—muscle cancer	0.00296	0.0352	CbGeAlD
Maprotiline—CHRM4—testis—muscle cancer	0.00286	0.034	CbGeAlD
Maprotiline—CHRM5—head—muscle cancer	0.00231	0.0275	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—muscle cancer	0.00201	0.0239	CbGeAlD
Maprotiline—CHRM3—renal system—muscle cancer	0.00193	0.023	CbGeAlD
Maprotiline—ORM1—bone marrow—muscle cancer	0.00192	0.0229	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—muscle cancer	0.00191	0.0227	CbGeAlD
Maprotiline—HTR7—renal system—muscle cancer	0.00184	0.0219	CbGeAlD
Maprotiline—Angiopathy—Vincristine—muscle cancer	0.00167	0.00424	CcSEcCtD
Maprotiline—Infestation—Etoposide—muscle cancer	0.00166	0.00422	CcSEcCtD
Maprotiline—Infestation NOS—Etoposide—muscle cancer	0.00166	0.00422	CcSEcCtD
Maprotiline—Mediastinal disorder—Vincristine—muscle cancer	0.00166	0.00421	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00165	0.00418	CcSEcCtD
Maprotiline—Dyskinesia—Doxorubicin—muscle cancer	0.00164	0.00416	CcSEcCtD
Maprotiline—Acute coronary syndrome—Etoposide—muscle cancer	0.00164	0.00416	CcSEcCtD
Maprotiline—Dysarthria—Doxorubicin—muscle cancer	0.00163	0.00413	CcSEcCtD
Maprotiline—Neuropathy peripheral—Etoposide—muscle cancer	0.00163	0.00413	CcSEcCtD
Maprotiline—Myocardial infarction—Etoposide—muscle cancer	0.00163	0.00413	CcSEcCtD
Maprotiline—Alopecia—Vincristine—muscle cancer	0.00163	0.00413	CcSEcCtD
Maprotiline—Jaundice—Etoposide—muscle cancer	0.00162	0.00411	CcSEcCtD
Maprotiline—Stomatitis—Etoposide—muscle cancer	0.00162	0.00411	CcSEcCtD
Maprotiline—Leukopenia—Dactinomycin—muscle cancer	0.00161	0.00407	CcSEcCtD
Maprotiline—Gynaecomastia—Methotrexate—muscle cancer	0.00159	0.00404	CcSEcCtD
Maprotiline—Atrioventricular block—Doxorubicin—muscle cancer	0.00159	0.00403	CcSEcCtD
Maprotiline—CHRM2—head—muscle cancer	0.00159	0.0189	CbGeAlD
Maprotiline—SLC6A3—head—muscle cancer	0.00158	0.0188	CbGeAlD
Maprotiline—Hepatobiliary disease—Etoposide—muscle cancer	0.00157	0.00399	CcSEcCtD
Maprotiline—Coordination abnormal—Doxorubicin—muscle cancer	0.00157	0.00398	CcSEcCtD
Maprotiline—Agranulocytosis—Etoposide—muscle cancer	0.00155	0.00393	CcSEcCtD
Maprotiline—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00154	0.00391	CcSEcCtD
Maprotiline—HTR2C—head—muscle cancer	0.00153	0.0182	CbGeAlD
Maprotiline—SLC6A3—testis—muscle cancer	0.00153	0.0182	CbGeAlD
Maprotiline—HTR2A—embryo—muscle cancer	0.00151	0.018	CbGeAlD
Maprotiline—Salivary hypersecretion—Doxorubicin—muscle cancer	0.0015	0.0038	CcSEcCtD
Maprotiline—Hypoaesthesia—Etoposide—muscle cancer	0.00149	0.00377	CcSEcCtD
Maprotiline—Urinary tract disorder—Etoposide—muscle cancer	0.00148	0.00374	CcSEcCtD
Maprotiline—Agitation—Vincristine—muscle cancer	0.00148	0.00374	CcSEcCtD
Maprotiline—Oedema—Dactinomycin—muscle cancer	0.00147	0.00371	CcSEcCtD
Maprotiline—CYP1A2—renal system—muscle cancer	0.00147	0.0174	CbGeAlD
Maprotiline—Urethral disorder—Etoposide—muscle cancer	0.00146	0.00371	CcSEcCtD
Maprotiline—Infection—Dactinomycin—muscle cancer	0.00146	0.00369	CcSEcCtD
Maprotiline—CHRM1—head—muscle cancer	0.00144	0.0172	CbGeAlD
Maprotiline—Leukopenia—Vincristine—muscle cancer	0.00144	0.00364	CcSEcCtD
Maprotiline—Thrombocytopenia—Dactinomycin—muscle cancer	0.00144	0.00364	CcSEcCtD
Maprotiline—HTR7—tendon—muscle cancer	0.00143	0.0171	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—muscle cancer	0.00143	0.017	CbGeAlD
Maprotiline—Erythema multiforme—Etoposide—muscle cancer	0.00141	0.00358	CcSEcCtD
Maprotiline—Eye disorder—Etoposide—muscle cancer	0.0014	0.00354	CcSEcCtD
Maprotiline—Convulsion—Vincristine—muscle cancer	0.00139	0.00352	CcSEcCtD
Maprotiline—Cardiac disorder—Etoposide—muscle cancer	0.00139	0.00351	CcSEcCtD
Maprotiline—Flushing—Etoposide—muscle cancer	0.00139	0.00351	CcSEcCtD
Maprotiline—Hypertension—Vincristine—muscle cancer	0.00139	0.00351	CcSEcCtD
Maprotiline—Angiopathy—Etoposide—muscle cancer	0.00136	0.00343	CcSEcCtD
Maprotiline—Mediastinal disorder—Etoposide—muscle cancer	0.00135	0.00341	CcSEcCtD
Maprotiline—Alopecia—Etoposide—muscle cancer	0.00132	0.00334	CcSEcCtD
Maprotiline—Cerebrovascular accident—Methotrexate—muscle cancer	0.00132	0.00334	CcSEcCtD
Maprotiline—Oedema—Vincristine—muscle cancer	0.00131	0.00332	CcSEcCtD
Maprotiline—Infection—Vincristine—muscle cancer	0.0013	0.0033	CcSEcCtD
Maprotiline—Osteoarthritis—Methotrexate—muscle cancer	0.00129	0.00328	CcSEcCtD
Maprotiline—CHRM3—head—muscle cancer	0.00129	0.0154	CbGeAlD
Maprotiline—Nervous system disorder—Vincristine—muscle cancer	0.00128	0.00326	CcSEcCtD
Maprotiline—Thrombocytopenia—Vincristine—muscle cancer	0.00128	0.00325	CcSEcCtD
Maprotiline—SLC6A2—head—muscle cancer	0.00128	0.0152	CbGeAlD
Maprotiline—Dysgeusia—Etoposide—muscle cancer	0.00127	0.00323	CcSEcCtD
Maprotiline—Hyperhidrosis—Vincristine—muscle cancer	0.00127	0.00321	CcSEcCtD
Maprotiline—Fatigue—Dactinomycin—muscle cancer	0.00126	0.0032	CcSEcCtD
Maprotiline—Vascular purpura—Doxorubicin—muscle cancer	0.00125	0.00317	CcSEcCtD
Maprotiline—CHRM3—testis—muscle cancer	0.00125	0.0148	CbGeAlD
Maprotiline—SLC6A2—testis—muscle cancer	0.00123	0.0147	CbGeAlD
Maprotiline—HTR7—head—muscle cancer	0.00123	0.0146	CbGeAlD
Maprotiline—Hypotension—Vincristine—muscle cancer	0.00122	0.0031	CcSEcCtD
Maprotiline—Ataxia—Methotrexate—muscle cancer	0.00122	0.00308	CcSEcCtD
Maprotiline—Feeling abnormal—Dactinomycin—muscle cancer	0.00121	0.00306	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0012	0.00304	CcSEcCtD
Maprotiline—Hot flush—Doxorubicin—muscle cancer	0.0012	0.00303	CcSEcCtD
Maprotiline—Liver function test abnormal—Methotrexate—muscle cancer	0.00119	0.00303	CcSEcCtD
Maprotiline—Increased appetite—Doxorubicin—muscle cancer	0.00119	0.00302	CcSEcCtD
Maprotiline—HTR2A—smooth muscle tissue—muscle cancer	0.00119	0.0142	CbGeAlD
Maprotiline—HTR7—testis—muscle cancer	0.00119	0.0141	CbGeAlD
Maprotiline—Menopausal symptoms—Doxorubicin—muscle cancer	0.00119	0.00301	CcSEcCtD
Maprotiline—Insomnia—Vincristine—muscle cancer	0.00118	0.003	CcSEcCtD
Maprotiline—Paraesthesia—Vincristine—muscle cancer	0.00118	0.00298	CcSEcCtD
Maprotiline—Breast disorder—Methotrexate—muscle cancer	0.00117	0.00296	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00116	0.00295	CcSEcCtD
Maprotiline—Leukopenia—Etoposide—muscle cancer	0.00116	0.00295	CcSEcCtD
Maprotiline—DRD2—head—muscle cancer	0.00116	0.0138	CbGeAlD
Maprotiline—Purpura—Doxorubicin—muscle cancer	0.00116	0.00294	CcSEcCtD
Maprotiline—Body temperature increased—Dactinomycin—muscle cancer	0.00116	0.00294	CcSEcCtD
Maprotiline—Abdominal pain—Dactinomycin—muscle cancer	0.00116	0.00294	CcSEcCtD
Maprotiline—HTR2A—renal system—muscle cancer	0.00115	0.0136	CbGeAlD
Maprotiline—Loss of consciousness—Etoposide—muscle cancer	0.00114	0.0029	CcSEcCtD
Maprotiline—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00114	0.0029	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Vincristine—muscle cancer	0.00113	0.00287	CcSEcCtD
Maprotiline—Fatigue—Vincristine—muscle cancer	0.00113	0.00286	CcSEcCtD
Maprotiline—Convulsion—Etoposide—muscle cancer	0.00113	0.00285	CcSEcCtD
Maprotiline—DRD2—testis—muscle cancer	0.00112	0.0134	CbGeAlD
Maprotiline—Hypertension—Etoposide—muscle cancer	0.00112	0.00284	CcSEcCtD
Maprotiline—Constipation—Vincristine—muscle cancer	0.00112	0.00284	CcSEcCtD
Maprotiline—Osteoarthritis—Doxorubicin—muscle cancer	0.00112	0.00284	CcSEcCtD
Maprotiline—Eosinophilia—Methotrexate—muscle cancer	0.00111	0.0028	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0011	0.00279	CcSEcCtD
Maprotiline—Gastrointestinal pain—Vincristine—muscle cancer	0.00107	0.00271	CcSEcCtD
Maprotiline—HRH1—tendon—muscle cancer	0.00107	0.0127	CbGeAlD
Maprotiline—Confusional state—Etoposide—muscle cancer	0.00107	0.00271	CcSEcCtD
Maprotiline—Pancytopenia—Methotrexate—muscle cancer	0.00106	0.00269	CcSEcCtD
Maprotiline—Infection—Etoposide—muscle cancer	0.00105	0.00267	CcSEcCtD
Maprotiline—Ataxia—Doxorubicin—muscle cancer	0.00105	0.00267	CcSEcCtD
Maprotiline—Asthenia—Dactinomycin—muscle cancer	0.00105	0.00267	CcSEcCtD
Maprotiline—CYP2D6—renal system—muscle cancer	0.00104	0.0124	CbGeAlD
Maprotiline—Thrombocytopenia—Etoposide—muscle cancer	0.00104	0.00263	CcSEcCtD
Maprotiline—Tachycardia—Etoposide—muscle cancer	0.00104	0.00262	CcSEcCtD
Maprotiline—Body temperature increased—Vincristine—muscle cancer	0.00104	0.00262	CcSEcCtD
Maprotiline—Abdominal pain—Vincristine—muscle cancer	0.00104	0.00262	CcSEcCtD
Maprotiline—Liver function test abnormal—Doxorubicin—muscle cancer	0.00103	0.00262	CcSEcCtD
Maprotiline—Skin disorder—Etoposide—muscle cancer	0.00103	0.00261	CcSEcCtD
Maprotiline—Erectile dysfunction—Methotrexate—muscle cancer	0.00103	0.00261	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—muscle cancer	0.00103	0.0026	CcSEcCtD
Maprotiline—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00102	0.00259	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—muscle cancer	0.00102	0.00259	CcSEcCtD
Maprotiline—Breast disorder—Doxorubicin—muscle cancer	0.00101	0.00256	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00101	0.00256	CcSEcCtD
Maprotiline—Diarrhoea—Dactinomycin—muscle cancer	0.001	0.00254	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—muscle cancer	0.000997	0.00253	CcSEcCtD
Maprotiline—Infestation—Methotrexate—muscle cancer	0.000997	0.00253	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—muscle cancer	0.000997	0.00253	CcSEcCtD
Maprotiline—HRH1—vagina—muscle cancer	0.000994	0.0118	CbGeAlD
Maprotiline—ABCB1—embryo—muscle cancer	0.000992	0.0118	CbGeAlD
Maprotiline—Hypotension—Etoposide—muscle cancer	0.000992	0.00251	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000988	0.0025	CcSEcCtD
Maprotiline—Muscular weakness—Doxorubicin—muscle cancer	0.000988	0.0025	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—muscle cancer	0.000971	0.00246	CcSEcCtD
Maprotiline—Dysphagia—Doxorubicin—muscle cancer	0.000968	0.00245	CcSEcCtD
Maprotiline—Eosinophilia—Doxorubicin—muscle cancer	0.000958	0.00243	CcSEcCtD
Maprotiline—Paraesthesia—Etoposide—muscle cancer	0.000953	0.00241	CcSEcCtD
Maprotiline—Somnolence—Etoposide—muscle cancer	0.000943	0.00239	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—muscle cancer	0.000943	0.00239	CcSEcCtD
Maprotiline—Asthenia—Vincristine—muscle cancer	0.00094	0.00238	CcSEcCtD
Maprotiline—Vomiting—Dactinomycin—muscle cancer	0.000932	0.00236	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—muscle cancer	0.00093	0.00236	CcSEcCtD
Maprotiline—Rash—Dactinomycin—muscle cancer	0.000924	0.00234	CcSEcCtD
Maprotiline—Pancytopenia—Doxorubicin—muscle cancer	0.000919	0.00233	CcSEcCtD
Maprotiline—HRH1—head—muscle cancer	0.000918	0.0109	CbGeAlD
Maprotiline—Gastrointestinal disorder—Etoposide—muscle cancer	0.000916	0.00232	CcSEcCtD
Maprotiline—Fatigue—Etoposide—muscle cancer	0.000915	0.00232	CcSEcCtD
Maprotiline—Constipation—Etoposide—muscle cancer	0.000907	0.0023	CcSEcCtD
Maprotiline—Diarrhoea—Vincristine—muscle cancer	0.000896	0.00227	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—muscle cancer	0.000895	0.00227	CcSEcCtD
Maprotiline—HTR2A—tendon—muscle cancer	0.000895	0.0106	CbGeAlD
Maprotiline—Pollakiuria—Doxorubicin—muscle cancer	0.000894	0.00227	CcSEcCtD
Maprotiline—HRH1—testis—muscle cancer	0.000887	0.0106	CbGeAlD
Maprotiline—Urinary tract disorder—Methotrexate—muscle cancer	0.000884	0.00224	CcSEcCtD
Maprotiline—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000883	0.00224	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—muscle cancer	0.000881	0.00223	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—muscle cancer	0.000877	0.00222	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—muscle cancer	0.000876	0.00222	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—muscle cancer	0.000874	0.00222	CcSEcCtD
Maprotiline—Nausea—Dactinomycin—muscle cancer	0.000871	0.00221	CcSEcCtD
Maprotiline—Gastrointestinal pain—Etoposide—muscle cancer	0.000868	0.0022	CcSEcCtD
Maprotiline—Dizziness—Vincristine—muscle cancer	0.000866	0.00219	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—muscle cancer	0.000863	0.00219	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—muscle cancer	0.000863	0.00219	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—muscle cancer	0.000863	0.00219	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000856	0.00217	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—muscle cancer	0.000846	0.00214	CcSEcCtD
Maprotiline—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000846	0.00214	CcSEcCtD
Maprotiline—Urticaria—Etoposide—muscle cancer	0.000843	0.00214	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—muscle cancer	0.000841	0.00213	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—muscle cancer	0.000841	0.00213	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—muscle cancer	0.000839	0.00213	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—muscle cancer	0.000839	0.00213	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—muscle cancer	0.000836	0.00212	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—muscle cancer	0.000834	0.00211	CcSEcCtD
Maprotiline—Vomiting—Vincristine—muscle cancer	0.000833	0.00211	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—muscle cancer	0.00083	0.0021	CcSEcCtD
Maprotiline—HTR2A—vagina—muscle cancer	0.00083	0.00988	CbGeAlD
Maprotiline—Rash—Vincristine—muscle cancer	0.000826	0.00209	CcSEcCtD
Maprotiline—Dermatitis—Vincristine—muscle cancer	0.000825	0.00209	CcSEcCtD
Maprotiline—Headache—Vincristine—muscle cancer	0.000821	0.00208	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000816	0.00207	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—muscle cancer	0.000812	0.00206	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—muscle cancer	0.000806	0.00204	CcSEcCtD
Maprotiline—Agranulocytosis—Doxorubicin—muscle cancer	0.000805	0.00204	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—muscle cancer	0.000791	0.002	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—muscle cancer	0.000779	0.00197	CcSEcCtD
Maprotiline—Nausea—Vincristine—muscle cancer	0.000778	0.00197	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—muscle cancer	0.000775	0.00196	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—muscle cancer	0.000771	0.00195	CcSEcCtD
Maprotiline—HTR2A—head—muscle cancer	0.000767	0.00912	CbGeAlD
Maprotiline—Urinary tract disorder—Doxorubicin—muscle cancer	0.000765	0.00194	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—muscle cancer	0.000763	0.00193	CcSEcCtD
Maprotiline—Asthenia—Etoposide—muscle cancer	0.000761	0.00193	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—muscle cancer	0.000759	0.00192	CcSEcCtD
Maprotiline—ABCB1—renal system—muscle cancer	0.000751	0.00894	CbGeAlD
Maprotiline—Pruritus—Etoposide—muscle cancer	0.000751	0.0019	CcSEcCtD
Maprotiline—HTR2A—testis—muscle cancer	0.000741	0.00881	CbGeAlD
Maprotiline—Vision blurred—Methotrexate—muscle cancer	0.000734	0.00186	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—muscle cancer	0.000733	0.00186	CcSEcCtD
Maprotiline—Diarrhoea—Etoposide—muscle cancer	0.000726	0.00184	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—muscle cancer	0.000724	0.00183	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—muscle cancer	0.000722	0.00183	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—muscle cancer	0.000719	0.00182	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—muscle cancer	0.000719	0.00182	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—muscle cancer	0.000703	0.00178	CcSEcCtD
Maprotiline—Dizziness—Etoposide—muscle cancer	0.000702	0.00178	CcSEcCtD
Maprotiline—CYP2D6—head—muscle cancer	0.000699	0.00831	CbGeAlD
Maprotiline—Mediastinal disorder—Doxorubicin—muscle cancer	0.000698	0.00177	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—muscle cancer	0.000697	0.00177	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—muscle cancer	0.000692	0.00175	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—muscle cancer	0.000685	0.00173	CcSEcCtD
Maprotiline—CYP2D6—testis—muscle cancer	0.000675	0.00803	CbGeAlD
Maprotiline—Convulsion—Methotrexate—muscle cancer	0.000675	0.00171	CcSEcCtD
Maprotiline—Vomiting—Etoposide—muscle cancer	0.000675	0.00171	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—muscle cancer	0.000674	0.00171	CcSEcCtD
Maprotiline—Rash—Etoposide—muscle cancer	0.000669	0.0017	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—muscle cancer	0.000668	0.00169	CcSEcCtD
Maprotiline—Headache—Etoposide—muscle cancer	0.000665	0.00168	CcSEcCtD
Maprotiline—Tension—Doxorubicin—muscle cancer	0.000662	0.00168	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—muscle cancer	0.00066	0.00167	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000659	0.00167	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—muscle cancer	0.000655	0.00166	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—muscle cancer	0.000641	0.00162	CcSEcCtD
Maprotiline—Vision blurred—Doxorubicin—muscle cancer	0.000636	0.00161	CcSEcCtD
Maprotiline—Infection—Methotrexate—muscle cancer	0.000631	0.0016	CcSEcCtD
Maprotiline—Nausea—Etoposide—muscle cancer	0.00063	0.0016	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—muscle cancer	0.000623	0.00158	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—muscle cancer	0.000622	0.00158	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—muscle cancer	0.00062	0.00157	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—muscle cancer	0.000617	0.00156	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—muscle cancer	0.000614	0.00156	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—muscle cancer	0.000605	0.00153	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—muscle cancer	0.000604	0.00153	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—muscle cancer	0.000596	0.00151	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—muscle cancer	0.000594	0.0015	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—muscle cancer	0.000593	0.0015	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—muscle cancer	0.000584	0.00148	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—muscle cancer	0.000582	0.00148	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—muscle cancer	0.000575	0.00146	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—muscle cancer	0.000572	0.00145	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—muscle cancer	0.000571	0.00145	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00057	0.00144	CcSEcCtD
Maprotiline—ABCB1—bone marrow—muscle cancer	0.000568	0.00676	CbGeAlD
Maprotiline—Somnolence—Methotrexate—muscle cancer	0.000565	0.00143	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—muscle cancer	0.000562	0.00142	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—muscle cancer	0.00056	0.00142	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—muscle cancer	0.000555	0.00141	CcSEcCtD
Maprotiline—Oedema—Doxorubicin—muscle cancer	0.00055	0.00139	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000549	0.00139	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—muscle cancer	0.000548	0.00139	CcSEcCtD
Maprotiline—Infection—Doxorubicin—muscle cancer	0.000547	0.00139	CcSEcCtD
Maprotiline—ABCB1—vagina—muscle cancer	0.000544	0.00647	CbGeAlD
Maprotiline—Shock—Doxorubicin—muscle cancer	0.000542	0.00137	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—muscle cancer	0.00054	0.00137	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—muscle cancer	0.000539	0.00137	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—muscle cancer	0.000537	0.00136	CcSEcCtD
Maprotiline—Skin disorder—Doxorubicin—muscle cancer	0.000535	0.00135	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—muscle cancer	0.000532	0.00135	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—muscle cancer	0.000524	0.00133	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—muscle cancer	0.00052	0.00132	CcSEcCtD
Maprotiline—Hypotension—Doxorubicin—muscle cancer	0.000514	0.0013	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—muscle cancer	0.000505	0.00128	CcSEcCtD
Maprotiline—ABCB1—head—muscle cancer	0.000503	0.00598	CbGeAlD
Maprotiline—Abdominal pain—Methotrexate—muscle cancer	0.000502	0.00127	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—muscle cancer	0.000502	0.00127	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—muscle cancer	0.000498	0.00126	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—muscle cancer	0.000494	0.00125	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—muscle cancer	0.000489	0.00124	CcSEcCtD
Maprotiline—ABCB1—testis—muscle cancer	0.000485	0.00578	CbGeAlD
Maprotiline—Dyspepsia—Doxorubicin—muscle cancer	0.000484	0.00123	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000475	0.0012	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—muscle cancer	0.000475	0.0012	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—muscle cancer	0.000471	0.00119	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—muscle cancer	0.000456	0.00116	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—muscle cancer	0.000454	0.00115	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00045	0.00114	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—muscle cancer	0.00045	0.00114	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—muscle cancer	0.000437	0.00111	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—muscle cancer	0.000435	0.0011	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—muscle cancer	0.000435	0.0011	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—muscle cancer	0.000435	0.0011	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—muscle cancer	0.00042	0.00106	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—muscle cancer	0.000404	0.00102	CcSEcCtD
Maprotiline—Rash—Methotrexate—muscle cancer	0.000401	0.00102	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—muscle cancer	0.0004	0.00101	CcSEcCtD
Maprotiline—Headache—Methotrexate—muscle cancer	0.000398	0.00101	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—muscle cancer	0.000395	0.001	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—muscle cancer	0.000389	0.000987	CcSEcCtD
Maprotiline—Nausea—Methotrexate—muscle cancer	0.000378	0.000957	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—muscle cancer	0.000377	0.000954	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—muscle cancer	0.000364	0.000922	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—muscle cancer	0.00035	0.000887	CcSEcCtD
Maprotiline—Rash—Doxorubicin—muscle cancer	0.000347	0.000879	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—muscle cancer	0.000347	0.000878	CcSEcCtD
Maprotiline—Headache—Doxorubicin—muscle cancer	0.000345	0.000874	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—muscle cancer	0.000327	0.000828	CcSEcCtD
